AzTrials
AzTrials

Intraoperative HypothermiaNCT06676735

Research on Intraoperative Hypothermia Risk Prediction Model and Temperature Management Strategy for Elderly Patients During Surgery Based on Dynamic Incremental Training

A study testing Inflatable warming system, Prediction of intraoperative hypothermia risk and The difference between axillary temperatature and core temperature in elderly patients in people with Intraoperative Hypothermia, run by First Affiliated Hospital of Chongqing Medical University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

With the support of partial dual temperature monitoring (comparing the specific difference between standardized axillary temperature monitoring and esophageal temperature), this trial is divided into the following three parts: 1. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Intraoperative Hypothermia
What is being tested?
Inflatable warming system, Prediction of intraoperative hypothermia risk and The difference between axillary temperatature and core temperature in elderly patients
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,323 participants
Where
1 siteChina
Study dates
11 Mar 2025to 14 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Elderly patients (aged 60 and above) undergoing non cardiac elective surgery under general anesthesia;
  • 30 minutes ≤ Estimated surgical duration ≤ 240 minutes ;
  • Normal preoperative bleeding and clotting time
  • American society of Aneshesiologists physical status classification system:Ⅰ~Ⅳ

Who cannot join

  • Mental illness
  • Cirrhosis
  • Existence or potential central hyperthermia
  • Metabolic thermoregulatory abnormalities
  • History of malignant hyperthermia or family history
  • Extensive skin burns or injuries
Show all 13Show fewer
  • Seriously infect
  • Long term use of nonsteroidal anti-inflammatory drugs
  • Expected difficult airway
  • Researchers believe that individuals who are not suitable to participate in clinical trial
  • Refusal to sign informed consent form
  • Withdraw informed consent form
  • Severe bleeding or shock during perioperative period.

Trial locations and contacts

1 site in 1 country.

China1 site
  • First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, 400010

Other trials in China

About this study

Official title: Research on Intraoperative Hypothermia Risk Prediction and Temperature Management Strategies in Elderly Patients: Construction of Intraoperative Hypothermia Prediction Model Based on Dynamic Incremental Training and Evaluation of Clinical Application Effectiveness

With the support of partial dual temperature monitoring (comparing the specific difference between standardized axillary temperature monitoring and esophageal temperature), this trial is divided into the following three parts:

  1. Multi center observational study: Establish and validate a dynamic incremental training intraoperative hypothermia prediction model - Intelligent Care for the Elderly (ICE) - Intraoperative hypothermia warning system, and provide ICE Offline for use by healthcare professionals and ICE Online for further model updates when needed for clinical or research purposes.
  2. Multi center non randomized controlled clinical trial: Conduct a multi center stratified temperature management clinical trial based on ICE Offline after dynamic incremental training to verify the clinical and economic benefits of the model and active warming.
  3. Pre and post comparative study: Collect data before ICE application and compare it with data after ICE promotion.
Being tested
Inflatable warming system, Prediction of intraoperative hypothermia risk, The difference between axillary temperatature and core temperature in elderly patients, Measurement of tympanic membrane temperature
Keywords
Intraoperative hypothermia, Prediction model, Elderly patients, Active warming, Machine Learning

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Inflatable warming systemDevice

    Inflatable warming system, including a forced air warming system (IOB, WU505) and forced air warming blanket (IOB-001, IOB-006, IOB-011), is employed for prewarming before anesthesia initiation and for maintaining body temperature throughout the operation. During the surgery, the insulation blanket will be applied to non surgical areas, and the host temperature will be adjusted to 38 ℃ for warming. If the temperature of the patient is lower than 36 ℃, the temperature of the system can be adjusted to 43 ℃; if the temperature of the patient is higher than 37 ℃, the temperature of the system can be adjusted to 32 ℃. After the patient\'s temperature is normal, it can be adjusted back to 38 ℃.

  • Prediction of intraoperative hypothermia riskDiagnostic test

    According to the Intelligent Care For The Elderly (ICE, an optimized model based on the existing prediction model of our research group after dynamic incremental training), patients are divided into intraoperative hypothermia lowrisk group and intraoperative hypothermia high risk group.

  • The difference between axillary temperatature and core temperature in elderly patientsOther

    Previous studies have shown that the difference and standard deviation between esophageal temperature and axillary temperature are core 0.05 ℃ and 0.26 ℃, respectively. In light of 10% dropout rate, a integer sample size of 400 achieves 95% power to detect a mean of paired differences of 0.05 with an estimated standard deviation of paired differences of 0.26 and with a significance level (alpha) of 0.05 using a two-sided paired t-test. So 400 patients in the Model optimization group need to undergo core temperature (esophageal temperature or nasopharyngeal temperature).

  • Measurement of tympanic membrane temperatureOther

    As a intraoperative core temperature reference (measure every 15 minutes) for patients without esophageal temperature or nasopharyngeal temperature monitoring.

Study groups in NCT06676735
Study groupRoleWhat they receive
Intraoperative hypothermia low risk groupExperimentalPatients included this group are determined by prediction model. Operating room environment temperature was set at not less than 21°C, with a relative humidity of 50% to 60%. Patients are covered from neck to feet with a cotton blanket and the area to be disinfected and operated on is uncovered after induction of anesthesia. All patients will be administered intravenous fluid warmers and irrigation fluid prewarming (37℃~43℃).
Receives: Diagnostic Test: Prediction of intraoperative hypothermia risk; Other: Measurement of tympanic membrane temperature
Intraoperative hypothermia high risk groupExperimentalPatients included this group are determined by prediction model. In addition to the measures taken in intraoperative hypothermia low risk group, an inflatable warming system, including a forced air warming system and forced air warming blanket, is employed for prewarming before anesthesia initiation and for maintaining body temperature throughout the operation. During the surgery, the insulation blanket will be applied to non surgical areas, and the host temperature will be adjusted to 38 ℃ for warming. If the temperature of the patient is lower than 36 ℃, the temperature of the system can be adjusted to 43 ℃; if the temperature of the patient is higher than 37 ℃, the temperature of the system can be adjusted to 32 ℃. After the patient's temperature is normal, it can be adjusted back to 38 ℃.
Receives: Device: Inflatable warming system; Diagnostic Test: Prediction of intraoperative hypothermia risk; Other: Measurement of tympanic membrane temperature
Model optimization groupOtherOnly observe the patient's baseline, intraoperative hypothermia, postoperative complications, and other indicators, and collect data through the electronic Data Capture System to optimize existing intraoperative hypothermia prediction model. The estimated sample size is 600 cases by the incremental learning curve calculating.
Receives: Other: The difference between axillary temperatature and core temperature in elderly patients; Other: Measurement of tympanic membrane temperature
Group of model benefit evaluationNo interventionData of this group is medical records before the application of the intraoperative hypothermia prediction model, which will be collected from the electronic medical record system.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intraoperative hypothermia

    Intraoperative hypothermia, defined as a core temperature below 36 °C

    Measured: Up to 24 hours, from the time of entry into the operating room to the time of exit from the operating room.

Secondary outcomes (16)
  1. The specificity and sensitivity of the model

    Conventional parameters for evaluating model accuracy

    Measured: 1 year

  2. Physical sensation

    The ASHRAE thermal sensation scale, which was developed for use in quantifying people's thermal sensation, is defined as follows:+3 (hot), +2 (warm), +1 (slightly warm), 0 (neutral), -1 (slightly cool), -2(cool), and -3 (cold)

    Measured: Perioperative period

  3. Total volume of intraoperative blood loss

    Routine intraoperative monitoring indicators

    Measured: Intraoperative

  4. Postoperative shivering

    A compensatory response of the body to hypothermic stimuli that cause rapid rhythmic. Once the operation is completed, the patient will be extubated and the presence or absence of shivering will be recorded up to 60 minutes after the extubation with the Badjatia 2008 scale consisting of a gradual evaluation of 0 to 3 points. With scores greater or equal to 1, shivering is considered established.

    Measured: Up to 60 minutes

  5. Postoperative coagulation index

    Routine postoperative monitoring indicators

    Measured: Within 24 hours after operation

  6. Postoperative hospital stay

    The number of days from the end of surgery to discharge displayed in the electronic medical record system for patients

    Measured: Through study completion, an average of 1 year

  7. Total hospital stay

    The number of days from admission to discharge displayed in the electronic medical record system for patients.

    Measured: Through study completion, an average of 1 year

  8. Costs of using active warming

    Measured: Perioperative period

  9. Postoperative hospital costs

    The Postoperative hospital cost (¥) from the end of surgery to discharge displayed in the electronic medical record system

    Measured: Through study completion, an average of 1 year

  10. Total hospital costs

    The Total hospital cost (¥) from admission to discharge displayed in the electronic medical record system

    Measured: Through study completion, an average of 1 year

  11. 30-day postoperative readmission

    Routine postoperative monitoring indicators

    Measured: 30 days after operation

  12. 30-day postoperative complications

    Routine postoperative monitoring indicators

    Measured: 30 days after operation

  13. 30-day postoperative mortality

    Routine postoperative monitoring indicators

    Measured: 30 days after operation

  14. Heart rate

    Obtained from multi parameter monitor

    Measured: Perioperative period

  15. Blood pressure

    Obtained from multi parameter monitor

    Measured: Perioperative period

  16. Blood oxygen saturation

    Obtained from multi parameter monitor

    Measured: Perioperative period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Nov 2024
  2. Study start11 Mar 2025
  3. Primary completion15 Dec 2025
  4. Study completion14 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
1,323 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06676735
Sponsor's protocol ID
ZZ2024-173-01
Status last verified
Jan 2026
First submitted
31 Oct 2024
Last updated
16 Jan 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data Data available: Yes Data types: Identified participant data How to access data: atpcr7@yeah.net When available: Within 5years after this trial Supporting Documents Document types: None Additional Information Who can access the data: Researchers whose proposed use of the data have been approved by Leader Sponsor and Principal Investigator of this trial. Types of analyses: To be discussed with the steering committee. Mechanisms of data availability: With investigator support after approval signed data access agreement. Any additional restrictions: None

Questions about this trial

What is this clinical trial studying?

A study testing Inflatable warming system, Prediction of intraoperative hypothermia risk and The difference between axillary temperatature and core temperature in elderly patients in people with Intraoperative Hypothermia, run by First Affiliated Hospital of Chongqing Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intraoperative hypothermia (time frame: Up to 24 hours, from the time of entry into the operating room to the time of exit from the operating room.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in